At CSI, we are proud of our long record of compliance; maintaining policies and practices that support strong corporate governance promoting ethical business practices and complete transparency in financial reporting. We continually review these practices and policies, modifying and enhancing them as needed.
Our highly experienced Board of Directors is constantly engaged in ensuring our corporate governance, resulting in our ability to foresee and incorporate front-edge practices and policies before they are formally mandated by corporate reform measures.
CSI is committed to observing appropriate governance policies and practices.
Our team is dedicated to collaborating with leading experts in the field to help patients get back to what matters. It includes executives experienced in medical devices, cardiovascular medicine and state-of-the-art technology. Read more about the Board of Directors and Executive Team.
We provide current and background materials for the investor community. We are committed to financial transparency. Review our comprehensive resources for investors and the media:
You can also sign up for regular email alerts or request additional investor information.